Literature DB >> 18480420

ACE-dependent and chymase-dependent angiotensin II generation in normal and glucose-stimulated human mesangial cells.

Priscila C Cristovam1, Carine P Arnoni, Maria Claudina C de Andrade, Dulce E Casarini, Luciana G Pereira, Nestor Schor, Mirian A Boim.   

Abstract

High glucose (HG) increases angiotensin II (AngII) generation in mesangial cells (MC). Chymase, an alternative AngII-generating enzyme, is upregulated in the glomeruli of diabetic kidneys. In this study, we examined AngII synthesis by human MC via angiotensin-converting enzyme (ACE)-dependent and chymase-dependent pathways under normal glucose (NG, 5 mM) and HG (30 mM) conditions. NG cells expressed ACE and chymase mRNA. Under NG conditions the chymase inhibitor chymostatin reduced AngII levels in cell lysates and in the culture medium, and the ACE inhibitor captopril had no effect. HG induced a 3-fold increase in chymase mRNA and protein but not in ACE mRNA; however, HG induced a 10-fold increase in intracellular ACE activity. The increase in AngII generation induced by HG was found in the cell lysate but not in the culture medium. The rise in intracellular AngII was not prevented by captopril or by chymostatin. Moreover, captopril inhibited extracellular ACE activity but failed to block intracellular ACE activity; these results suggested that captopril was unable to reach intra-cellular ACE. Losartan did not change the intracellular AngII content in either NG or HG conditions, and this lack of change suggested that the increase in AngII was due to intracellular generation. Together these results suggest that chymase may be active in human MC and that both ACE and chymase are involved in increased AngII generation during the HG stimulus by different mechanisms, including an upregulation of chymase mRNA and a rise in intracellular ACE activity, favoring the generation and accumulation of intracellular AngII.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480420     DOI: 10.3181/0708-RM-229

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  23 in total

Review 1.  Intracardiac intracellular angiotensin system in diabetes.

Authors:  Rajesh Kumar; Qian Chen Yong; Candice M Thomas; Kenneth M Baker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

Review 2.  Inflammation and therapy for hypertension.

Authors:  Cheryl L Laffer; Fernando Elijovich
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

Review 3.  The intracrine renin-angiotensin system.

Authors:  Rajesh Kumar; Candice M Thomas; Qian Chen Yong; Wen Chen; Kenneth M Baker
Journal:  Clin Sci (Lond)       Date:  2012-09       Impact factor: 6.124

Review 4.  Mitochondrial angiotensin receptors and cardioprotective pathways.

Authors:  Nelson Escobales; Rebeca E Nuñez; Sabzali Javadov
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-04-12       Impact factor: 4.733

Review 5.  G protein-coupled receptor signalling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function.

Authors:  Artavazd Tadevosyan; George Vaniotis; Bruce G Allen; Terence E Hébert; Stanley Nattel
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

Review 6.  Subcellular characteristics of functional intracellular renin-angiotensin systems.

Authors:  Peter M Abadir; Jeremy D Walston; Robert M Carey
Journal:  Peptides       Date:  2012-09-29       Impact factor: 3.750

7.  Angiotensin I is largely converted to angiotensin (1-7) and angiotensin (2-10) by isolated rat glomeruli.

Authors:  Juan Carlos Q Velez; Kevin J Ryan; Caroline E Harbeson; Alison M Bland; Milos N Budisavljevic; John M Arthur; Wayne R Fitzgibbon; John R Raymond; Michael G Janech
Journal:  Hypertension       Date:  2009-03-16       Impact factor: 10.190

Review 8.  The intracellular renin-angiotensin system in the heart.

Authors:  Rajesh Kumar; Vivek P Singh; Kenneth M Baker
Journal:  Curr Hypertens Rep       Date:  2009-04       Impact factor: 5.369

9.  Network modeling reveals steps in angiotensin peptide processing.

Authors:  John H Schwacke; John Christian G Spainhour; Jessalyn L Ierardi; Jose M Chaves; John M Arthur; Michael G Janech; Juan Carlos Q Velez
Journal:  Hypertension       Date:  2013-01-02       Impact factor: 10.190

10.  Human recombinant ACE2 reduces the progression of diabetic nephropathy.

Authors:  Gavin Y Oudit; George C Liu; Jiuchang Zhong; Ratnadeep Basu; Fung L Chow; Joyce Zhou; Hans Loibner; Evelyne Janzek; Manfred Schuster; Josef M Penninger; Andrew M Herzenberg; Zamaneh Kassiri; James W Scholey
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.